Clinical Trials · NCT00000400
Alendronate and/or Parathyroid Hormone for Osteoporosis
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 176
- Start date
- Aug 1999
- Locations
- 1 site, United States
- Primary endpoint
- change in spine bone mineral density